Ankur Sharma leads the Oncofetal Ecosystem Laboratory at the Harry Perkins Institute of Medical Research and Curtin University. He completed his PhD at the Indian Institute of Science, where he won the Best PhD Thesis award, and then completed postdoctoral training at the Genome Institute of Singapore. A trailblazer in single-cell genomics and spatial transcriptomics, Ankur is responsible for ground-breaking research that has given rise to the novel ‘Oncofetal Ecosystems’ field, with a foundational paper in Cell. This pioneering work has garnered widespread acceptance within the scientific community, making oncofetal cell profiling a routine task in the Liver Cancer Collaborative networks. The oncofetal ecosystem concept has received resounding endorsement from the scientific and clinical communities, demonstrated by the more-than-50 invitations Ankur has received to speak at prestigious scientific and clinical events. The impact of his research is already substantial, with the recent launch of the master observational trial TRACKERx (funded by the MRFF EMCR grant in 2022) and the investigator-initiated clinical trial PLANET2.0. Subsequent publications from Ankur in esteemed journals such as Cell, Science, Immunity, Nature Cancer Review, and Nature Cancer further illustrate the significance of this work. Ankur received funding from NHMRC Ideas Grant (CIA), MRFF EMCR grant (CIA), and CSL Centenary Fellowship.